Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | RGS12 | O14924 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | TERT | O14746 | 7/20 | 0.43 |
| ▸ | APP | P05067 | 1/20 | 0.41 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17190564 | 0.95 | STAT3 (0.47) | STAT3HIF1AMEN1RGS12HTT | |
| SCHEMBL17190544 | 0.92 | STAT3 (0.46) | STAT3HIF1AMEN1RGS12HTT | |
| SCHEMBL17190577 | 0.90 | STAT3 (0.40) | STAT3HIF1AMEN1RGS12HTT | |
| SCHEMBL17190565 | 0.88 | STAT3 (0.49) | STAT3HIF1AMEN1RGS12HTT | |
| SCHEMBL15810558 | 0.85 | STAT3 (0.39) | STAT3HIF1AMEN1RGS12HTT | |
| SCHEMBL17190557 | 0.83 | STAT3 (0.41) | STAT3HIF1AMEN1RGS12HTT | |
| SCHEMBL8071104 | 0.83 | STAT3 (0.65) | STAT3HIF1AMEN1RGS12HTT | |
| SCHEMBL18379137 | 0.83 | STAT3 (0.65) | STAT3HIF1AMEN1RGS12HTT | |
| SCHEMBL418871 | 0.83 | STAT3 (0.65) | STAT3HIF1AMEN1RGS12HTT | |
| SCHEMBL18376159 | 0.83 | STAT3 (0.65) | STAT3HIF1AMEN1RGS12HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170267929-A1 | DEVICE FOR REGULATING THE PASSAGE OF ENERGY | MERCK PATENT GMBH (DE) | 2017-09-21 | — | — | US | disclosed |
| US-9701905-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2017-07-11 | — | — | US | disclosed |
| US-20160319592-A1 | DEVICE FOR REGULATING THE PASSAGE OF LIGHT | MERCK PATENT GMBH (DE) | 2016-11-03 | — | — | US | disclosed |
| US-20160108317-A1 | DEVICE FOR CONTROLLING THE PASSAGE OF ENERGY, CONTAINING A DICHROIC DYE COMPOUND | MERCK PATENT GMBH (DE) | 2016-04-21 | — | — | US | disclosed |
| US-20160033807-A1 | DEVICE FOR REGULATING THE PASSAGE OF ENERGY | MERCK PATENT GMBH (DE) | 2016-02-04 | — | — | US | disclosed |
| US-20150315473-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2015-11-05 | — | — | US | disclosed |
| US-20150299577-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2015-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160108317-A1 | DEVICE FOR CONTROLLING THE PASSAGE OF ENERGY, CONTAINING A DICHROIC DYE COMPOUND | CRY1, SLC25A1, CRY2 | STAT3 4607/4885HIF1A 2799/4885MEN1 589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.